Marchand Institute, the First Major Research Group to Include Statement of Diversity and Inclusion on All Publications – Now Recommends for All Research Institutions

March 15, 2022Minimally Invasive Surgery, OBGYNBy gmarchand

FOR IMMEDIATE RELEASE

MESA, Ariz. — March 15, 2022

Since 2019, The Marchand Institute has displayed a paragraph on all publications proudly stating their dedication to diversity, inclusion, and the maintenance of a workplace free of racism and sexism. This declaration, in accordance with our not-for-profit mission for women’s health, is very much a part of what we are as a leading research institute. We strongly value the diverse backgrounds of our brilliant research staff, and seek to continue to add diverse individuals to our team. As of today, as a leader in surgical research, we now recommend that all research institutions follow our lead and include a statement on diversity and inclusion in all of their publications. From our perspective this is equally as important as the required statements disclosing conflicts of interest and sources of funding. An example of this statement can be found in our published works in many top level prestigious journals (JAMA, Gray Journal, etc. etc.), and an example is below:

“Statement on Commitment to Diversity and Inclusion: The Marchand Institute remains committed to diversity and tolerance in its research, and actively maintains a workplace free of racism and sexism. Greater than half of the authors for this study are female, and many represent diverse backgrounds and under-represented ethnic groups.”

About the Marchand Institute for Minimally Invasive Surgery

The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.

Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905

Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.

###